Markers of Alzheimer's disease in a population attending a memory clinic

Alzheimer's and Dementia

Volumn 5, Issue 4, 2009, Pages 307-317

  Frisoni, Giovanni B ^a   Prestia, Annapaola ^a   Zanetti, Orazio ^a   Galluzzi, Samantha ^a   Romano, Melissa ^a   Cotelli, Maria ^a   Gennarelli, Massimo ^a,b   Binetti, Giuliano ^a   Bocchio, Luisella ^a   Paghera, Barbara ^c   Amicucci, Giovanni ^d   Bonetti, Matteo ^e   Benussi, Luisa ^a   Ghidoni, Roberta ^a   Geroldi, Cristina ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Nuclear Medicine Service   (Italy)

^d S Orsola Hospital   (Italy)

^e Istituto Clinico Citta di Brescia   (Italy)

Author keywords

Alzheimer's disease; Biological markers; Mild cognitive impairment; Preclinical diagnosis

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FLUORODEOXYGLUCOSE F 18; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN METABOLISM; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ATROPHY; BIOLOGICAL MARKERS; CEREBRAL CORTEX; COGNITION DISORDERS; COHORT STUDIES; FEMALE; GLUCOSE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 67649962188     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2009.04.1235     Document Type: Article

References (50)

1. Robertson E.D., and Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 314 (2006) 781-784
2. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., et al. Current concepts in mild cognitive impairment. Arch Neurol 58 (2001) 1985-1992
3. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
4. Petersen R.C., Parisi J.E., Dickson D.W., Johnson K.A., Knopman D.S., Boeve B.F., et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63 (2006) 665-672
5. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58 (2001) 397-405
6. Arai H., Higuchi S., and Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology 43 (1997) 2-10
7. Gabryelewicz T., Styczynska M., Luczywek E., Barczak A., Pfeffer A., Androsiuk W., et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 22 (2007) 563-567
8. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., et al. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
10. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (2007) 734-746
11. Cockrell J.R., and Folstein M.F. Mini-Mental State Examination (MMSE). Psychopharmacol Bull 24 (1988) 689-692
12. Lawton M.P., and Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9 (1969) 179-186
13. De Leo D., Frisoni G.B., Rozzini R., and Trabucchi M. Italian community norms for the Brief Symptom Inventory in the elderly. Br J Clin Psychol 32 (1993) 209-213
14. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbei J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
15. Lezak M., Howieson D., and Loring D.W. Neuropsychological Assessment. 4th ed. (2004), Oxford University Press, Oxford
16. McKeith I.G. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9 (2006) 417-423
17. Knopman D.S., Boeve B.F., and Petersen R.C. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 78 (2003) 1290-1308
18. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 5 (1994) 189-192
19. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 (1999) 33-39
20. McKhann G.M., Albert M.S., Grossman M., Miller B., Dickson D., Trojanowski J.Q., et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58 (2001) 1803-1809
21. Collins D.L., Neelin P., Peters T.M., and Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18 (1994) 192-205
22. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55 (1992) 967-972
23. Sjögren M., Vanderstichele H., Agren H., Zachrisson O., Edsbagge M., Wikkelsø C., et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47 (2001) 1776-1781
24. Valk J., Barkof T., and Scheltens P. Magnetic Resonance in Dementia (2002), Springer Verlag, Berlin
25. Frisoni G.B., Scheltens P., Galluzzi S., Nobili F.M., Fox N.C., Robert P.H., et al. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry 74 (2003) 1371-1381
26. O'Brien T.J., Newton M.R., Cook M.J., Berlangieri S.U., Kilpatrick C., Morris K., et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 38 (1997) 74-80
27. Signorini M., Paulesu E., Friston K., Perani D., Colleluori A., Lucignani G., et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9 (1999) 63-80
28. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frölich L., et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17 (2002) 302-316
29. Zetterberg H., Wahlund L.O., and Blennow K. Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett 352 (2003) 67-69
30. Blennow K., and Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2 (2003) 605-613
31. van Norden A.G., Fick W.F., de Laat K.F., van Uden I.W., van Oudheusden L.J., Tendolkar I., et al. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. Neurology 71 (2008) 1152-1159
32. St John P., and Montgomery P. Are cognitively intact seniors with subjective memory loss more likely to develop dementia?. Int J Geriatr Psychiatry 17 (2002) 814-820
33. Camicioli R., Moore M.M., Kinney A., Corbridge E., Glassberg K., and Kaye J.A. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 18 (2003) 784-790
34. Hashimoto M., Kitagaki H., Imamura T., Hirono N., Shimomura T., Kazui H., et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 51 (1998) 357-362
35. Frisoni G.B., Laakso M.P., Beltramello A., Geroldi C., Bianchetti A., Soininen H., et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52 (1999) 91-100
36. Frisoni G.B., Padovani A., and Wahlund L.O. The diagnosis of Alzheimer disease before it is Alzheimer dementia. Arch Neurol 60 (2003) 1023-1024
37. Larrieu S., Letenneur L., Orgogozo J.M., Fabrigoule C., Amieva H., Le Carret C., et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59 (2002) 1594-1599
38. Petersen R.C., and Negash S. Mild cognitive impairment: an overview. CNS Spectr 13 (2008) 45-53
39. Jagust W., Reed B., Mungas D., Ellis W., and Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?. Neurology 69 (2007) 871-877
40. Silverman D.H., Small G.W., Chang C.Y., Lu C.S., Kung De Aburto M.A., Chen W., et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286 (2001) 2120-2127
41. Hoffman J.M., Welsh-Bohmer K.A., Hanson M., Crain B., Hulette C., Earl N., et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 41 (2000) 1920-1928
42. Blennow K., and Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2 (2003) 605-613
43. Brandt C., Bahl J., Heegaard N.H.H., Waldemar G., and Johannsen P. Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic. Dement Geriatr Cogn Disord 25 (2008) 553-558
44. Hansson O., Zetterberg H., Buchhave P., Andreasson U., Londos E., Minthon L., et al. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord 23 (2007) 316-320
45. Hoyer J., Becker E.S., Neumer S., Soeder U., and Margraf J. Screening for anxiety in an epidemiological sample: predictive accuracy of questionnaires. J Anxiety Disord 16 (2002) 113-134
46. Morris R.K., Cnossen J.S., Langejans M., Robson S.C., Kleijnen J., Ter Riet G., et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. Pregnancy Childbirth 8 (2008) 33
47. Butcher J. Alzheimer's researchers open the doors to data sharing. Lancet Neurol 6 (2007) 480-481
48. Lewczuk P., Kornhuber J., Vanderstichele H., Vanmechelen E., Esselmann H., Bibl M., et al. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging 29 (2008) 812-818
49. Colliot O., Chételat G., Chupin M., Desgranges B., Magnin B., Benali H., et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 248 (2008) 194-201
50. Signorini M., Paulesu E., Friston K., Perani D., Colleluori A., Lucignani G., et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9 (1999) 63-80